| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 679404 | 73828 | ATORVASTATINA TARBIS 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA TARBIS 20 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73828/73828_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73828/73828_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | TARBIS FARMA S.L. | 2011-04-07 | 1 | 1 | 1 | 2011-04-07 | 2011-04-07 | 1 | 2011-07-13 | View Edit Delete | ||||||||||||
| 679408 | 73830 | ATORVASTATINA TARBIS 40 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA TARBIS 40 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73830/73830_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73830/73830_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | TARBIS FARMA S.L. | 2011-04-07 | 1 | 1 | 1 | 2011-04-07 | 2011-04-07 | 1 | 2011-07-13 | View Edit Delete | ||||||||||||
| 679411 | 73832 | ATORVASTATINA TARBIS 80 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | ATORVASTATINA TARBIS 80 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 80 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73832/73832_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73832/73832_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | TARBIS FARMA S.L. | 2011-04-07 | 1 | 1 | 1 | 2011-04-07 | 2011-04-07 | 1 | 2011-07-13 | View Edit Delete | ||||||||||||
| 680369 | 74034 | REPAGLINIDA TARBIS 0,5 MG COMPRIMIDOS EFG | REPAGLINIDA TARBIS 0,5 MG COMPRIMIDOS EFG , 90 comprimidos | 0,5 mg | 5 | 90 | 10 | 90 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/74034/74034_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/74034/74034_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | TARBIS FARMA S.L. | 2011-05-13 | 1 | 1 | 1 | 2011-05-13 | 2011-05-13 | 1 | 2014-09-10 | View Edit Delete | ||||||||||||
| 680383 | 74037 | REPAGLINIDA TARBIS 1 MG COMPRIMIDOS EFG | REPAGLINIDA TARBIS 1 MG COMPRIMIDOS EFG , 90 comprimidos | 1 mg | 5 | 90 | 10 | 90 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/74037/74037_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/74037/74037_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | TARBIS FARMA S.L. | 2011-05-13 | 1 | 1 | 1 | 2011-05-13 | 2011-05-13 | 1 | 2014-09-10 | View Edit Delete | ||||||||||||
| 680386 | 74039 | REPAGLINIDA TARBIS 2 MG COMPRIMIDOS EFG | REPAGLINIDA TARBIS 2 MG COMPRIMIDOS EFG , 90 comprimidos | 2 mg | 5 | 90 | 10 | 90 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/74039/74039_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/74039/74039_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | TARBIS FARMA S.L. | 2011-05-13 | 1 | 1 | 1 | 2011-05-13 | 2011-05-13 | 1 | 2014-09-10 | View Edit Delete | ||||||||||||
| 680841 | 74133 | ACIDO IBANDRONICO TARBIS 150 mg COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | ACIDO IBANDRONICO TARBIS 150 mg COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG , 1 comprimido | 150 mg | 5 | 1 | 10 | 1 comprimido | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/74133/74133_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/74133/74133_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | TARBIS FARMA S.L. | 2011-05-30 | 1 | 1 | 1 | 2011-05-30 | 2011-05-30 | 1 | 2014-05-13 | View Edit Delete | ||||||||||||
| 680842 | 74133 | ACIDO IBANDRONICO TARBIS 150 mg COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG | ACIDO IBANDRONICO TARBIS 150 mg COMPRIMIDOS RECUBIERTOS CON PELÍCULA EFG , 3 comprimidos | 150 mg | 5 | 3 | 10 | 3 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/74133/74133_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/74133/74133_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2876 | TARBIS FARMA S.L. | 2011-05-30 | 1 | 1 | 1 | 2011-05-30 | 2011-05-30 | 1 | 2014-05-13 | View Edit Delete | ||||||||||||
| 679597 | 61076 | MOVALIS 15 mg COMPRIMIDOS | MOVALIS 15 mg COMPRIMIDOS , 20 comprimidos | 15 mg | 5 | 20 | 10 | 20 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61076/61076_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61076/61076_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5126 | BOEHRINGER INGELHEIM ESPANA S.A. | 1996-10-01 | 1 | 1 | 1 | 1996-10-01 | 1996-10-01 | 1 | 2011-10-25 | View Edit Delete | ||||||||||||
| 679605 | 61075 | MOVALIS 7,5 mg COMPRIMIDOS | MOVALIS 7,5 mg COMPRIMIDOS, 20 comprimidos | 7,5 mg | 5 | 20 | 10 | 20 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/61075/61075_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/61075/61075_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5126 | BOEHRINGER INGELHEIM ESPANA S.A. | 1996-10-01 | 1 | 1 | 1 | 1996-10-01 | 1996-10-01 | 1 | 2011-10-25 | View Edit Delete | ||||||||||||
| 679565 | 73875 | LACIDIPINO TEVA 4 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | LACIDIPINO TEVA 4 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos | 4 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73875/73875_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73875/73875_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 34492 | TEVA GENERICOS ESPAÑOLA S.L. | 2011-04-13 | 1 | 1 | 1 | 2011-04-13 | 2011-04-13 | 1 | 2012-01-25 | View Edit Delete | ||||||||||||
| 677306 | 73273 | EXEMESTANO KERN PHARMA 25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | EXEMESTANO KERN PHARMA 25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 30 comprimidos | 25 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73273/73273_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73273/73273_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2011-01-10 | 1 | 1 | 1 | 2025-04-14 | 2025-04-14 | 1 | 2025-04-15 | View Edit Delete | ||||||||||||
| 677308 | 73322 | BROMAZEPAM KERN PHARMA 1,5 mg CAPSULAS EFG | BROMAZEPAM KERN PHARMA 1,5 mg CAPSULAS EFG, 30 cápsulas | 1,5 mg | 5 | 30 | 43 | 30 cápsulas | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73322/73322_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73322/73322_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2011-01-24 | 1 | 1 | 1 | 2011-01-24 | 2011-01-24 | 1 | 2011-04-04 | Lista IV | View Edit Delete | |||||||||||
| 677311 | 73321 | BROMAZEPAM KERN PHARMA 3 mg CAPSULAS EFG | BROMAZEPAM KERN PHARMA 3 mg CAPSULAS EFG, 30 cápsulas | 3 mg | 5 | 30 | 43 | 30 cápsulas | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73321/73321_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73321/73321_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2011-01-24 | 1 | 1 | 1 | 2011-01-24 | 2011-01-24 | 1 | 2011-04-04 | Lista IV | View Edit Delete | |||||||||||
| 677413 | 73340 | IRBESARTAN/HIDROCLOROTIAZIDA KERN PHARMA 300 mg/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | IRBESARTAN/HIDROCLOROTIAZIDA KERN PHARMA 300 mg/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos | 300 mg/25 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73340/73340_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73340/73340_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2011-01-26 | 1 | 1 | 1 | 2011-01-26 | 2011-01-26 | 1 | 2011-04-28 | View Edit Delete | ||||||||||||
| 677414 | 73341 | IRBESARTAN/HIDROCLOROTIAZIDA KERN PHARMA 150 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | IRBESARTAN/HIDROCLOROTIAZIDA KERN PHARMA 150 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 150 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73341/73341_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73341/73341_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2011-01-26 | 1 | 1 | 1 | 2011-01-26 | 2011-01-26 | 1 | 2011-04-28 | View Edit Delete | ||||||||||||
| 677415 | 73342 | IRBESARTAN/HIDROCLOROTIAZIDA KERN PHARMA 300 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | IRBESARTAN/HIDROCLOROTIAZIDA KERN PHARMA 300 mg/12,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 28 comprimidos | 300 mg/12,5 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73342/73342_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73342/73342_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2011-01-26 | 1 | 1 | 1 | 2011-01-26 | 2011-01-26 | 1 | 2011-04-28 | View Edit Delete | ||||||||||||
| 677479 | 68071 | PANTOPRAZOL KERN PHARMA 40 mg COMPRIMIDOS GASTRORRESISTENTES EFG | PANTOPRAZOL KERN PHARMA 40 mg COMPRIMIDOS GASTRORRESISTENTES EFG, 14 comprimidos | 40 mg | 5 | 14 | 10 | 14 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68071/68071_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68071/68071_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2006-10-09 | 1 | 1 | 1 | 2006-10-09 | 2011-02-02 | 1 | 2015-07-21 | View Edit Delete | ||||||||||||
| 677480 | 68071 | PANTOPRAZOL KERN PHARMA 40 mg COMPRIMIDOS GASTRORRESISTENTES EFG | PANTOPRAZOL KERN PHARMA 40 mg COMPRIMIDOS GASTRORRESISTENTES EFG, 28 comprimidos | 40 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/68071/68071_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/68071/68071_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2006-10-09 | 1 | 1 | 1 | 2006-10-09 | 2011-02-02 | 1 | 2014-08-09 | View Edit Delete | ||||||||||||
| 677561 | 73494 | VALSARTAN/HIDROCLOROTIAZIDA KERN PHARMA 320 mg/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | VALSARTAN/HIDROCLOROTIAZIDA KERN PHARMA 320 mg/25 mg COMPRIMIDOS RECUBIERTOS CON PELICULA EFG , 28 comprimidos | 320 mg/25 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/73494/73494_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/73494/73494_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1534 | KERN PHARMA S.L. | 2011-02-10 | 1 | 1 | 1 | 2011-02-10 | 2011-02-10 | 1 | 2011-05-17 | View Edit Delete |
Page 275 of 1036, showing 20 records out of 20704 total, starting on record 5481, ending on 5500